# A Unique Case of Cutaneous Schwannoma With Coexistent Masson's Hemangioma

**Authors:** Svetlana Bobkova, Eli P Oldham, Igor Shendrik

PMC · DOI: 10.7759/cureus.63600 · Cureus · 2024-07-01

## TL;DR

A 60-year-old woman had a skin tumor that combined a schwannoma with a rare vascular lesion called Masson's hemangioma, a previously unreported combination.

## Contribution

This is the first documented case of a schwannoma containing Masson's hemangioma.

## Key findings

- The schwannoma exhibited a central area of thrombosis and vascular proliferation consistent with Masson's hemangioma.
- Immunohistochemical staining confirmed schwannoma and hemangioma features using S100 and ERG markers.
- The coexistence of these two distinct lesions highlights a rare pathological interaction.

## Abstract

Schwannomas (SCHs) are benign neural tumors originating from Schwann cells of the peripheral nerve sheaths. These neoplasms typically exhibit hyalinized vessels with impaired vascular permeability; however, angioma-like features are rare. We report an intriguing case of a cutaneous SCH with unusual vascular changes in a 60-year-old female who presented with a tender nodular lesion on her lower back. Histopathological examination of the excised lesion revealed a schwannoma with a central area of thrombosis and a vascular proliferative lesion consistent with Masson's hemangioma (MH). MH, also known as intravascular papillary endothelial hyperplasia (IPEH), is a rare benign vascular lesion characterized by papillary endothelial hyperplasia and obliterative changes within vascular lumens. Immunohistochemical staining confirmed S100 positivity in the SCH component and highlighted the papillary endothelial lining by ERG (erythroblast transformation-specific regulated gene 1). To our knowledge, this is the first report of a schwannoma harboring MH. This unique case underscores the potential for rare vascular proliferation to arise within otherwise typical SCHs.

## Linked entities

- **Proteins:** S100A1 (S100 calcium binding protein A1), ERG (ETS transcription factor ERG)

## Full-text entities

- **Genes:** ERG (ETS transcription factor ERG) [NCBI Gene 2078] {aka LMPHM14, erg-3, p55}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}
- **Diseases:** neoplasms (MESH:D009369), Cutaneous Schwannoma (MESH:D009442), lesion (MESH:D009059), IPEH (MESH:D002291), MH (MESH:D006391), benign vascular lesion (MESH:D014652), thrombosis (MESH:D013927)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11290594/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11290594/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC11290594/full.md

---
Source: https://tomesphere.com/paper/PMC11290594